GlobeNewswire Inc.··NaAgios Pharmaceuticals Eyes Accelerated FDA Approval Path for Mitapivat in Sickle Cell
Agios Pharmaceuticals to report Q1 2026 results April 29 amid FDA accelerated approval pursuit for sickle cell mitapivat and UAE thalassemia approval.
AGIOrare diseasesFDA